Honz Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 174.6 million compared to CNY 109.95 million a year ago. Revenue was CNY 174.6 million compared to CNY 109.95 million a year ago.

Net income was CNY 15.41 million compared to net loss of CNY 46.24 million a year ago. Basic earnings per share from continuing operations was CNY 0.0343 compared to basic loss per share from continuing operations of CNY 0.1028 a year ago. Diluted earnings per share from continuing operations was CNY 0.0343 compared to diluted loss per share from continuing operations of CNY 0.1028 a year ago.